Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy
Clinical trial NCT07565415 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07565415
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-22
- Primary completion
- 2027-09-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.